Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma

BackgroundRadiological evaluation of postchemotherapy residual masses of metastatic seminoma is characterized by poor diagnostic accuracy. Serum levels of microRNA-371a-3p (M371) involve high specificity and sensitivity for the primary diagnosis of seminoma. We evaluated if M371 levels can indicate...

Full description

Bibliographic Details
Main Authors: Klaus-Peter Dieckmann, Markus Klemke, Francesca Grobelny, Arlo Radtke, Inken Dralle-Filiz, Christian Wülfing, Gazanfer Belge
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
seminoma
metastases
chemotherapy
microRNA
M371
residual tumor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.889624/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.889624/full

Similar Items